Rein Therapeutics Stock Analysis

Rein Stock Analysis Notes

About 37.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.05. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Rein Therapeutics recorded a loss per share of 2.88. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 11th of November 2022. To find out more about Rein Therapeutics contact James Windsor at 737 802 1989 or learn more at https://www.reintx.com.

Rein Therapeutics Investment Alerts

Rein Largest EPS Surprises

View All Earnings Estimates

Rein Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 52.86 M.

Rein Profitablity

Management Efficiency

Rein Therapeutics has return on total asset (ROA) of (0.3163) % which means that it has lost $0.3163 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5495) %, meaning that it created substantial loss on money invested by shareholders. Rein Therapeutics' management efficiency ratios could be used to measure how well Rein Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -4.37 in 2025. Return On Capital Employed is likely to rise to -1.1 in 2025. At this time, Rein Therapeutics' Non Current Assets Total are fairly stable compared to the past year. Other Current Assets is likely to rise to about 1.2 M in 2025, whereas Total Assets are likely to drop slightly above 43.2 M in 2025.

Technical Drivers

As of the 22nd of July, Rein Therapeutics holds the Variance of 20.85, coefficient of variation of (2,730), and Risk Adjusted Performance of (0.03). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rein Therapeutics, as well as the relationship between them.

Rein Therapeutics Price Movement Analysis

Rein Therapeutics Outstanding Bonds

Rein Therapeutics Predictive Daily Indicators

Rein Therapeutics Forecast Models

Rein Therapeutics' time-series forecasting models are one of many Rein Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Rein Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Rein Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Rein shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Rein Therapeutics. By using and applying Rein Stock analysis, traders can create a robust methodology for identifying Rein entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Rein analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Rein analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Rein Therapeutics stock analysis indicators help investors evaluate how Rein Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Rein Therapeutics shares will generate the highest return on investment. By understating and applying Rein Therapeutics stock analysis, traders can identify Rein Therapeutics position entry and exit signals to maximize returns.

When running Rein Therapeutics' price analysis, check to measure Rein Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rein Therapeutics is operating at the current time. Most of Rein Therapeutics' value examination focuses on studying past and present price action to predict the probability of Rein Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rein Therapeutics' price. Additionally, you may evaluate how the addition of Rein Therapeutics to your portfolios can decrease your overall portfolio volatility.